Page 1 | Search Results | Blood | American Society of Hematology

1-15 of 15

Sort by

Sort Order Select

Journal Articles

iPLA2β Contributes to Activation of Human and Mouse Platelets Via ITAM Receptors Fcγ RIIA and GPVI

Shaji Abraham, PhD, Pravin Patel, BA, Ulhas P. Naik, PhD, Steven Edward McKenzie, MD PhD

Blood (2019) 134 (Supplement_1): 2339.

https://doi.org/10.1182/blood-2019-128426

Published: 2019

Journal Articles

The Effect of Rivaroxaban Exposure and Clinical Risk Factors on Efficacy and Safety Outcomes in Patients with Nonvalvular Atrial Fibrillation

Xiaoyu Yan, PhD MSc, Gary Peters, MD, Amarnath Sharma, Partha Nandy, Christopher Nessel, MD, Dirk Garmann, Stefan Willmann, Anne Hermanowski-Vosatka, Alexander Solms, Scott D. Berkowitz, MD, Theodore E Spiro, MD, Keith A A Fox, MBBS, Jeffrey I Weitz, MD FRCPC, FACP, Stephan Schmidt, Jonathan P Piccini, Manesh Patel, Richard C Becker, Liping Zhang

Blood (2017) 130 (Supplement 1): 1107.

https://doi.org/10.1182/blood.V130.Suppl_1.1107.1107

Published: 2017

Journal Articles

CD69 Expression Predicts Favorable Outcome in Multiple Myeloma Patients Treated with VTD

Gabriele Buda, MD, Giovanni Carulli, Enrico Orciuolo, Paola Sammuri, Sara Galimberti, MD, Martina Rousseau, MD, Francesca Martini, Mario Petrini

Blood (2015) 126 (23): 1768.

https://doi.org/10.1182/blood.V126.23.1768.1768

Published: 2015

Journal Articles

Metabolomic Profiling Identifies Hypoxia-Induced Imbalanced Lands' Cycle Promotes Sickling and Disease Progression

Hongyu Wu, PhD, Mikhail Bogdanov, PhD, Yujin Zhang, MD, Kaiqi Sun, BS, Anren Song, PhD, Hong Liu, MD, Morayo G, Adebiyi, Danny C. Alexander, Michael V. Milburn, Modupe Idowu, MD, Harinder S. Juneja, MD, Yang Xia, MD PhD

Blood (2015) 126 (23): 2134.

https://doi.org/10.1182/blood.V126.23.2134.2134

Published: 2015

Journal Articles

CD69, a New Potential Clinical Marker in Multiple Myeloma

Gabriele Buda, MD, Giovanni Carulli, Enrico Orciuolo, Paola Sammuri, Daniele Campa, PhD, Sara Galimberti, Mario Petrini, MD

Blood (2014) 124 (21): 2027.

https://doi.org/10.1182/blood.V124.21.2027.2027

Published: 2014

Journal Articles

Peroxiredoxin 6 Enhances Phagocyte NADPH Oxidase (phox) Activity in Response to Agonists Acting Via Cell Surface Receptors and Intracellular Signaling Pathways.

Michael A. Ellison, PhD, Daniel R. Ambruso, MD, Gail Thurman, BS

Blood (2012) 120 (21): 2139.

https://doi.org/10.1182/blood.V120.21.2139.2139

Published: 2012

Journal Articles

Lipids: Free Fatty Acids, Eicosanoids, and Lysophospholipids and the Pro-Inflammatory Effects of Transfusion

Christopher C. Silliman, MD, PhD

Blood (2012) 120 (21): SCI-48.

https://doi.org/10.1182/blood.V120.21.SCI-48.SCI-48

Published: 2012

Journal Articles

Inflammation-associated lysophospholipids as ligands for CD1d-restricted T cells in human cancer

David H. Chang, Haiteng Deng, Phillip Matthews, Joseph Krasovsky, Govind Ragupathi, Radek Spisek, Amitabha Mazumder, David H. Vesole, Sundar Jagannath, Madhav V. Dhodapkar

Blood (2008) 112 (4): 1308–1316.

https://doi.org/10.1182/blood-2008-04-149831

Published: 2008

Journal Articles

Prolonged Survival of Chronic Lymphocytic Leukemia Cells Induced by Sphingosine 1-Phosphate Is Mediated by the G Protein-Coupled Receptor S1P1 and Involves Erk/MAP Kinase, but Not Akt Signaling.

Gabriele Seitz, Sedat Yildirim, Andreas Boehmler, Lothar Kanz, Robert Mohle

Blood (2006) 108 (11): 2801.

https://doi.org/10.1182/blood.V108.11.2801.2801

Published: 2006

Journal Articles

Lysophospholipid Acylation in RBC.

Eric Soupene, PhD, Frans A. Kuypers, PhD

Blood (2006) 108 (11): 1575.

https://doi.org/10.1182/blood.V108.11.1575.1575

Published: 2006

Journal Articles

Acyl-CoA Turnover in RBC.

Eric Soupene, PhD, Melvin Siliakus, Frans A. Kuypers, PhD

Blood (2006) 108 (11): 1579.

https://doi.org/10.1182/blood.V108.11.1579.1579

Published: 2006

Journal Articles

Cytosolic phospholipase A 2 type IVA is present in human red cells

Donald J. Macdonald, Rose M. Boyle, Alastair C. A. Glen, David F. Horrobin

Blood (2004) 103 (9): 3562–3564.

https://doi.org/10.1182/blood-2002-09-2698

Published: 2004

Journal Articles

Lysophospholipids synergistically promote primitive hematopoietic cell chemotaxis via a mechanism involving Vav 1

Anthony D. Whetton, Yuning Lu, Andrew Pierce, Louise Carney, Elaine Spooncer

Blood (2003) 102 (8): 2798–2802.

https://doi.org/10.1182/blood-2002-12-3635

Published: 2003

Journal Articles

Sphingosine 1-phosphate as a major bioactive lysophospholipid that is released from platelets and interacts with endothelial cells

Yutaka Yatomi, Tsukasa Ohmori, Ge Rile, Fuminori Kazama, Hirotaka Okamoto, Takamitsu Sano, Kaneo Satoh, Shoji Kume, Gabor Tigyi, Yasuyuki Igarashi, Yukio Ozaki

Blood (2000) 96 (10): 3431–3438.

https://doi.org/10.1182/blood.V96.10.3431

Published: 2000

Journal Articles

Sphingosine-1-phosphate is a ligand for the G protein-coupled receptor EDG-6

James R. Van Brocklyn, Markus H. Gräler, Günter Bernhardt, John P. Hobson, Martin Lipp, Sarah Spiegel

Blood (2000) 95 (8): 2624–2629.

https://doi.org/10.1182/blood.V95.8.2624

Published: 2000

NARROW

iPLA2β Contributes to Activation of Human and Mouse Platelets Via ITAM Receptors Fcγ RIIA and GPVI

The Effect of Rivaroxaban Exposure and Clinical Risk Factors on Efficacy and Safety Outcomes in Patients with Nonvalvular Atrial Fibrillation

CD69 Expression Predicts Favorable Outcome in Multiple Myeloma Patients Treated with VTD

Metabolomic Profiling Identifies Hypoxia-Induced Imbalanced Lands' Cycle Promotes Sickling and Disease Progression

CD69, a New Potential Clinical Marker in Multiple Myeloma

Peroxiredoxin 6 Enhances Phagocyte NADPH Oxidase (phox) Activity in Response to Agonists Acting Via Cell Surface Receptors and Intracellular Signaling Pathways.

Lipids: Free Fatty Acids, Eicosanoids, and Lysophospholipids and the Pro-Inflammatory Effects of Transfusion

Inflammation-associated lysophospholipids as ligands for CD1d-restricted T cells in human cancer

Prolonged Survival of Chronic Lymphocytic Leukemia Cells Induced by Sphingosine 1-Phosphate Is Mediated by the G Protein-Coupled Receptor S1P1 and Involves Erk/MAP Kinase, but Not Akt Signaling.

Lysophospholipid Acylation in RBC.

Acyl-CoA Turnover in RBC.

Cytosolic phospholipase A 2 type IVA is present in human red cells

Lysophospholipids synergistically promote primitive hematopoietic cell chemotaxis via a mechanism involving Vav 1

Sphingosine 1-phosphate as a major bioactive lysophospholipid that is released from platelets and interacts with endothelial cells

Sphingosine-1-phosphate is a ligand for the G protein-coupled receptor EDG-6

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only